Latest & greatest articles for mammography

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on mammography or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on mammography and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for mammography

201. UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening.

UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening. 7488893 1996 01 04 1996 01 04 2016 11 23 0959-8138 311 7014 1995 Nov 04 BMJ (Clinical research ed.) BMJ UKCCCR multicentre randomised controlled trial of one and two view mammography in breast cancer screening. 1189-93 To compare one view (oblique) and two view (oblique and craniocaudal) mammography in breast cancer screening. Randomised controlled trial. Nine breast screening centres (...) in England. 40,163 women aged 50-64 attending their first breast screening examination. Women were randomised to have one view mammography, two view mammography, or two view mammography in which one view was read by one reader and both views were read by another. Prevalence of cancer detected, recall rates, cost per cancer detected, and marginal cost per extra cancer detected. Two view mammography detected 24% more women with breast cancer (95% confidence interval 16% to 31%) than one view mammography

BMJ1995 Full Text: Link to full Text with Trip Pro

202. Screening mammography in women aged 40-49 years: analysis of cost effectiveness

Screening mammography in women aged 40-49 years: analysis of cost effectiveness Screening mammography in women aged 40-49 years: analysis of cost effectiveness Screening mammography in women aged 40-49 years: analysis of cost effectiveness Rosenquist C J, Lindfors K K Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed (...) critical assessment on the reliability of the study and the conclusions drawn. Health technology Programme of annual mammography. Type of intervention Secondary prevention. Economic study type Cost-effectiveness analysis Study population Hypothetical cohort of women aged between 45-49. Setting Primary care. The economic study was carried out in the USA. Dates to which data relate Cost data were in part collected from 1990 and 1994 studies. Price date was not specified. Source of effectiveness data

NHS Economic Evaluation Database.1994

203. Breast cancer screening with mammography: overview of Swedish randomised trials.

Breast cancer screening with mammography: overview of Swedish randomised trials. 8096941 1993 05 11 1993 05 11 2016 11 23 0140-6736 341 8851 1993 Apr 17 Lancet (London, England) Lancet Breast cancer screening with mammography: overview of Swedish randomised trials. 973-8 Despite encouraging results from screening trials the efficacy of mammography in reducing mortality remains somewhat controversial. Five studies have been done in Sweden. This overview, based on 282,777 women followed for 5-13 (...) years in randomised trials in Malmö, Kopparberg, Ostergötland, Stockholm, and Gothenburg, reveals a 24% (95% confidence interval 13-34%) significant reduction of breast cancer mortality among those invited to mammography screening compared with those not invited. To avoid the potential risk of differential misclassification causes of death were assessed by an independent end-point committee after a blinded review of all fatal breast cancer cases. The mortality reduction was similar, irrespective

Lancet1993

204. The value of mammography screening in women under age 50 years

The value of mammography screening in women under age 50 years The value of mammography screening in women under age 50 years The value of mammography screening in women under age 50 years Eddy D M, Hasselblad V, McGivney W, Hendee W Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability (...) of the study and the conclusions drawn. Health technology Mammography, clinical examination. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Women aged 40-49 years. Setting The study was carried out in the USA. Dates to which data relate Price related to 1984. Source of effectiveness data Review of studies. Modelling Epidemiological cohort model (model of survival and disease). Measure of benefits used in the economic analysis Life-years gained. Direct

NHS Economic Evaluation Database.1988

205. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare.

Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. 2858707 1985 05 17 1985 05 17 2016 11 23 0140-6736 1 8433 1985 Apr 13 Lancet (London, England) Lancet Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare (...) . 829-32 A randomised controlled trial to investigate the efficacy of mass screening with single-view mammography in reducing mortality from breast cancer was started in Sweden in 1977. 162 981 women aged 40 years or more and living in the counties of Kopparberg and Ostergötland were enrolled in the study and divided at random into 2 groups. Each woman in the study group was offered screening every 2 or 3 years depending on age. Women in the control group were not offered screening. This report

Lancet1985

206. Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981.

Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981. 6144933 1984 07 06 1984 07 06 2016 11 23 0140-6736 1 8388 1984 Jun 02 Lancet (London, England) Lancet Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981. 1222-4 Since 1975 four rounds of screening with modern mammography for breast cancer have been carried out among 30 000 (...) Neoplasms diagnostic imaging mortality prevention & control Clinical Trials as Topic Female Humans Mammography Mass Screening Middle Aged Netherlands Random Allocation 1984 6 2 1984 6 2 0 1 1984 6 2 0 0 ppublish 6144933

Lancet1984